Standard BioTools approves severance plans for CEO, CFO, and CBO through 2028

STANDARD BIOTOOLS INC.

2026 Severance Plan for CFO Alex Kim and CBO Sean Mackay: outside COC, 12 months salary, prorated bonus, COBRA subsidy, equity acceleration if terminated by Aug 27, 2026.
During COC: non-CEOs receive 150% of salary plus target bonus lump sum, 18 months COBRA, and full equity vesting.
CEO Michael Egholm covered under 2023 Severance Plan: outside COC, 200% salary over 24 months, 12 months COBRA, outplacement.
During COC: CEO gets 250% of salary plus bonus lump sum, 30 months COBRA, and full equity vesting.
2026 Severance Plan supersedes the 2024 plan; both plans expire August 4, 2028.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.